Therapeutic Area | MeSH |
---|---|
mental disorders | D001523 |
Brand Name | Status | Last Update |
---|---|---|
mirtazapine | ANDA | 2025-07-22 |
remeron | New Drug Application | 2012-02-17 |
remeron remeronsoltab | New Drug Application | 2025-02-24 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
depressive disorder | EFO_1002014 | D003866 | F32.A |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Drug common name | Mirtazapine |
INN | mirtazapine |
Description | Mirtazapine is a benzazepine and a tetracyclic antidepressant. It has a role as an alpha-adrenergic antagonist, a serotonergic antagonist, a histamine antagonist, an anxiolytic drug, a H1-receptor antagonist and a oneirogen. |
Classification | Small molecule |
Drug class | tricyclic compounds |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CN1CCN2c3ncccc3Cc3ccccc3C2C1 |
PDB | — |
CAS-ID | 61337-67-5 |
RxCUI | — |
ChEMBL ID | CHEMBL654 |
ChEBI ID | 6950 |
PubChem CID | 4205 |
DrugBank | DB00370 |
UNII ID | A051Q2099Q (ChemIDplus, GSRS) |